State Street Corporation reveals a 4.1% ownership stake in CytomX Therapeutics, indicating strategic interest in the pharmaceutical sector.
| Name | CytomX Therapeutics, Inc. |
|---|---|
| CIK | 0001501989 |
| Tickers | CTMX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 273521219 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 650.515.3185 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
State Street Corporation reveals a 4.1% ownership stake in CytomX Therapeutics, indicating strategic interest in the pharmaceutical sector.
CytomX Therapeutics files Q3 report, detailing financials and collaborations, impacting the pharmaceutical preparations industry.
CytomX Therapeutics sees a significant update as Bank of America reports a 5.4% stake in the company, reflecting trends in the pharmaceutical preparations industry.
801 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000642 | 005-89140 | 261537899 | 34 | 8118 | |||
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-449787 | 001-37587 | 261527258 | 34 | 509570 | 1 | 1 |
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-449739 | 001-37587 | 261527077 | 34 | 11146365 | 1 | 1 | |
| 2026-10-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000528 | 005-89140 | 261494841 | 34 | 171584 | |||
| 2026-10-16 | 4/A | FORM 4/A | 0001610717-26-000442 | 10901 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005484 | 005-89140 | 261281343 | 34 | 12400 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001907884-26-000014 | 005-89140 | 261278518 | 34 | 9569 | |||
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000448 | 005-89140 | 261251758 | 34 | 8153 | |||
| 2026-08-06 | S-8 | S-8 | 0001193125-26-338121 | 333-298059 | 261249503 | 33 | 227565 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-338009 | 001-37587 | 261249098 | 34 | 477088 | 1 | 1 |
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-337950 | 001-37587 | 261248874 | 34 | 9860272 | 1 | 1 | |
| 2026-08-05 | 4 | FORM 4 | 0001610717-26-000351 | 7720 | ||||||
| 2026-08-05 | 3 | FORM 3 | 0001610717-26-000350 | 10670 | ||||||
| 2026-08-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000395 | 005-89140 | 261231342 | 34 | 171510 | |||
| 2026-07-30 | 4 | FORM 4 | 0001610717-26-000345 | 5680 | ||||||
| 2026-07-30 | 3 | FORM 3 | 0001610717-26-000344 | 11085 | ||||||
| 2026-07-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002247 | 005-89140 | 261206069 | 34 | 11013 | |||
| 2026-07-27 | 8-K | 8-K | 5.02 | 0001193125-26-316929 | 001-37587 | 261202881 | 34 | 139395 | 1 | 1 |
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000280 | 5318 | ||||||
| 2026-06-22 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0001193125-26-277631 | 001-37587 | 261107832 | 34 | 337251 | 1 | 1 |
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000279 | 5388 | ||||||
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000278 | 5373 | ||||||
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000277 | 5363 | ||||||
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000276 | 5373 | ||||||
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000275 | 5386 | ||||||
| 2026-06-22 | 4 | xslF345X06/form4.xml | 0001610717-26-000274 | 5373 | ||||||
| 2026-06-17 | 4 | xslF345X06/form4.xml | 0001610717-26-000229 | 4822 | ||||||
| 2026-06-03 | 8-K | 8-K | 1.01 | 0001193125-26-255467 | 001-37587 | 261060789 | 34 | 138886 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001013594-26-000617 | 005-89140 | 26989662 | 34 | 17876 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-227057 | 005-89140 | 26989100 | 34 | 21140 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001738048-26-000064 | 005-89140 | 26988784 | 34 | 18274 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001907884-26-000010 | 005-89140 | 26986638 | 34 | 9574 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-226556 | 005-89140 | 26986543 | 34 | 10865 | |||
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-211920 | 001-37587 | 26953396 | 34 | 360411 | 1 | 1 |
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-211868 | 001-37587 | 26953142 | 34 | 8283107 | 1 | 1 | |
| 2026-04-30 | DEFA14A | DEFA14A | 0001140361-26-018248 | 001-37587 | 26925685 | 34 | 1376744 | |||
| 2026-04-30 | DEF 14A | DEF 14A | 0001140361-26-018237 | 001-37587 | 26925607 | 34 | 6425427 | 1 | 1 | |
| 2026-04-20 | PRE 14A | PRE 14A | 0001140361-26-015658 | 001-37587 | 26875225 | 34 | 6417860 | 1 | 1 | |
| 2026-04-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-002013 | 005-89140 | 26867650 | 34 | 18230 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-001034 | 005-89140 | 26799710 | 34 | 7226 | |||
| 2026-03-19 | 4 | xslF345X06/form4.xml | 0001610717-26-000125 | 4773 | ||||||
| 2026-03-19 | 4 | xslF345X06/form4.xml | 0001610717-26-000124 | 5629 | ||||||
| 2026-03-19 | 4 | xslF345X06/form4.xml | 0001610717-26-000123 | 4783 | ||||||
| 2026-03-19 | 4 | xslF345X06/form4.xml | 0001610717-26-000122 | 4752 | ||||||
| 2026-03-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-115958 | 001-37587 | 26774236 | 34 | 635708 | 1 | 1 |
| 2026-03-18 | 424B5 | 424B5 | 0001193125-26-113931 | 333-294342 | 26768907 | 33 | 698636 | 1 | 1 | |
| 2026-03-16 | 424B5 | 424B5 | 0001193125-26-108461 | 333-294342 | 26757391 | 33 | 560377 | |||
| 2026-03-16 | S-3ASR | S-3ASR | 0001193125-26-108302 | 333-294342 | 26756502 | 33 | 824800 | 1 | 1 | |
| 2026-03-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-107152 | 001-37587 | 26754423 | 34 | 413442 | 1 | 1 |
| 2026-03-16 | 10-K | 10-K | 0001193125-26-107146 | 001-37587 | 26754419 | 34 | 16726330 | 1 | 1 | |
| 2026-03-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001907884-26-000006 | 005-89140 | 26720806 | 34 | 9364 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-26-000190 | 005-89140 | 26644297 | 34 | 7443 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-26-002019 | 005-89140 | 26641468 | 34 | 13433 | |||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000388 | 005-89140 | 26601853 | 34 | 11633 | |||
| 2026-02-04 | 4 | xslF345X05/form4.xml | 0001610717-26-000043 | 9739 | ||||||
| 2026-02-04 | 4 | xslF345X05/form4.xml | 0001610717-26-000042 | 7386 | ||||||
| 2026-02-04 | 4 | xslF345X05/form4.xml | 0001610717-26-000041 | 7400 | ||||||
| 2026-02-04 | 4 | xslF345X05/form4.xml | 0001610717-26-000040 | 7365 | ||||||
| 2026-02-04 | 4 | xslF345X05/form4.xml | 0001610717-26-000039 | 8251 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001738048-25-000016 | 005-89140 | 251488390 | 34 | 17861 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-005005 | 005-89140 | 251486023 | 34 | 12009 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001013594-25-001422 | 005-89140 | 251483236 | 34 | 25944 | |||
| 2025-11-10 | 4 | xslF345X05/form4.xml | 0001610717-25-000372 | 6065 | ||||||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002911 | 005-89140 | 251461152 | 34 | 11633 | |||
| 2025-11-06 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-050396 | 001-37587 | 251460162 | 33 | 4502 | |||
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-269533 | 001-37587 | 251458404 | 34 | 454012 | 1 | 1 |
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269477 | 001-37587 | 251458236 | 34 | 11688407 | 1 | 1 | |
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002714 | 005-89140 | 251452598 | 34 | 11632 | |||
| 2025-10-29 | 4 | xslF345X05/form4.xml | 0001610717-25-000370 | 5498 | ||||||
| 2025-10-29 | 3 | xslF345X02/form3.xml | 0001610717-25-000369 | 10136 | ||||||
| 2025-09-30 | 4 | xslF345X05/form4.xml | 0001610717-25-000357 | 7793 | ||||||
| 2025-09-30 | 4 | xslF345X05/form4.xml | 0001610717-25-000356 | 7778 | ||||||
| 2025-09-30 | 4 | xslF345X05/form4.xml | 0001610717-25-000355 | 7757 | ||||||
| 2025-09-30 | 4 | xslF345X05/form4.xml | 0001610717-25-000354 | 7792 | ||||||
| 2025-08-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-110649 | 005-89140 | 251240647 | 34 | 10612 | |||
| 2025-08-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002666 | 333-289365 | 251229558 | 33 | 1786 | ||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000947871-25-000782 | 005-89140 | 251221548 | 34 | 7252 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003701 | 005-89140 | 251221266 | 34 | 12093 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-012267 | 005-89140 | 251219283 | 34 | 14089 | |||
| 2025-08-14 | CORRESP | filename1.htm | 0001193125-25-180756 | 6596 | ||||||
| 2025-08-13 | UPLOAD | filename1.pdf | 0000000000-25-008499 | 333-289365 | 40193 | |||||
| 2025-08-13 | 8-K | 8-K | 8.01 | 0001193125-25-179463 | 001-37587 | 251209061 | 34 | 141116 | 1 | 1 |
| 2025-08-07 | S-8 | S-8 | 0001193125-25-175473 | 333-289370 | 251194603 | 33 | 198343 | 1 | 1 | |
| 2025-08-07 | S-3 | S-3 | 0001193125-25-175465 | 333-289365 | 251194556 | 33 | 905482 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-105053 | 001-37587 | 251194277 | 34 | 409552 | 1 | 1 |
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-104991 | 001-37587 | 251193931 | 34 | 9826729 | 1 | 1 | |
| 2025-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-001984 | 005-89140 | 251188313 | 34 | 11138 | |||
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000780 | 005-89140 | 251159052 | 34 | 6256 | |||
| 2025-07-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-001982 | 005-89140 | 251114604 | 34 | 24686 | |||
| 2025-07-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000921895-25-001981 | 005-89140 | 251114598 | 34 | 26114 | |||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0001610717-25-000236 | 10115 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0001610717-25-000235 | 8478 | ||||||
| 2025-06-17 | 4 | xslF345X05/form4.xml | 0001610717-25-000234 | 9333 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000215 | 5253 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000214 | 5322 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000213 | 5307 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000212 | 5297 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000211 | 5308 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000210 | 5307 | ||||||
| 2025-06-13 | 4 | xslF345X05/form4.xml | 0001610717-25-000209 | 5320 | ||||||
| 2025-06-13 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-25-140739 | 001-37587 | 251046573 | 34 | 326620 | 1 | 1 |
| 2025-05-28 | 8-K | 8-K | 8.01 | 0001193125-25-129470 | 001-37587 | 25995457 | 34 | 135982 | 1 | 1 |
| 2025-05-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001013594-25-000691 | 005-89140 | 25970650 | 34 | 23049 | 1 | 1 | |
| 2025-05-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-075515 | 005-89140 | 25970645 | 34 | 114937 | |||
| 2025-05-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-013803 | 005-89140 | 25969129 | 34 | 34846 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-007872 | 005-89140 | 25953332 | 34 | 29764 | |||
| 2025-05-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002330 | 005-89140 | 25947070 | 34 | 17042 | |||
| 2025-05-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-118805 | 001-37587 | 25939945 | 34 | 400678 | 1 | 1 |
| 2025-05-12 | 424B5 | 424B5 | 0001193125-25-117880 | 333-281433 | 25935836 | 33 | 527718 | |||
| 2025-05-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-117245 | 001-37587 | 25932489 | 34 | 247375 | 1 | 1 |
| 2025-05-12 | 10-Q | 10-Q | 0000950170-25-068511 | 001-37587 | 25932453 | 34 | 8258617 | 1 | 1 | |
| 2025-04-28 | DEFA14A | DEFA14A | 0001140361-25-016028 | 001-37587 | 25880609 | 34 | 4778564 | |||
| 2025-04-28 | DEF 14A | DEF 14A | 0001140361-25-016026 | 001-37587 | 25880561 | 34 | 5931835 | 1 | 1 | |
| 2025-03-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000086 | 5569 | ||||||
| 2025-03-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000085 | 4731 | ||||||
| 2025-03-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000084 | 4695 | ||||||
| 2025-03-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000083 | 4649 | ||||||
| 2025-03-20 | 4 | xslF345X05/form4.xml | 0001610717-25-000082 | 4724 | ||||||
| 2025-03-06 | S-8 | S-8 | 0001193125-25-048412 | 333-285594 | 25715221 | 33 | 85713 | |||
| 2025-03-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-034585 | 001-37587 | 25715161 | 34 | 342323 | 1 | 1 |
| 2025-03-06 | 10-K | 10-K | 0000950170-25-034575 | 001-37587 | 25715108 | 34 | 14369550 | 1 | 1 | |
| 2025-02-26 | 8-K | 8-K | 3.01 | 0001193125-25-036794 | 001-37587 | 25670631 | 34 | 147983 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000043 | 005-89140 | 25625164 | 34 | 9570 | |||
| 2025-02-10 | 4/A | xslF345X05/form4.xml | 0001610717-25-000020 | 12512 | ||||||
| 2025-02-06 | 4 | xslF345X05/form4.xml | 0001610717-25-000019 | 11570 | ||||||
| 2025-02-06 | 4 | xslF345X05/form4.xml | 0001610717-25-000018 | 11541 | ||||||
| 2025-02-06 | 4 | xslF345X05/form4.xml | 0001610717-25-000017 | 11578 | ||||||
| 2025-02-06 | 4 | xslF345X05/form4.xml | 0001610717-25-000016 | 12418 | ||||||
| 2025-02-03 | 8-K | 8-K | 5.02 | 0001193125-25-019257 | 001-37587 | 25582446 | 34 | 148643 | 1 | 1 |
| 2025-01-06 | 8-K | 8-K | 2.05 | 0001193125-25-002165 | 001-37587 | 25511179 | 34 | 153166 | 1 | 1 |
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0000921895-24-002717 | 005-89140 | 241462947 | 34 | 283447 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO.3 | 0001214659-24-019106 | 005-89140 | 241461374 | 34 | 136549 | |||
| 2024-11-14 | SC 13G/A | cormorant-ctmx093024a1.htm | 0001172661-24-005044 | 005-89140 | 241460728 | 34 | 87721 | |||
| 2024-11-14 | SC 13G/A | JANUS AMENDMENT | 0001274173-24-000114 | 005-89140 | 241459396 | 34 | 13103 | |||
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-123314 | 001-37587 | 241435694 | 34 | 413783 | 1 | 1 |
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123249 | 001-37587 | 241435425 | 34 | 8155558 | 1 | 1 | |
| 2024-08-22 | 4 | xslF345X05/form4.xml | 0001610717-24-000436 | 10360 | ||||||
| 2024-08-22 | 4 | xslF345X05/form4.xml | 0001610717-24-000435 | 8785 | ||||||
| 2024-08-22 | 4 | xslF345X05/form4.xml | 0001610717-24-000434 | 8891 | ||||||
| 2024-08-22 | 4 | xslF345X05/form4.xml | 0001610717-24-000433 | 8789 | ||||||
| 2024-08-22 | 4 | xslF345X05/form4.xml | 0001610717-24-000432 | 9631 | ||||||
| 2024-08-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-08-19 16:00:00 | 9999999995-24-002578 | 333-281433 | 241222517 | 33 | 1793 | ||
| 2024-08-15 | CORRESP | filename1.htm | 0001193125-24-201304 | 6923 | ||||||
| 2024-08-15 | UPLOAD | filename1.pdf | 0000000000-24-009362 | 333-281433 | 40085 | |||||
| 2024-08-09 | S-3 | S-3 | 0001193125-24-197826 | 333-281433 | 241192601 | 33 | 966559 | |||
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093936 | 001-37587 | 241188314 | 34 | 417565 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-093865 | 001-37587 | 241188093 | 34 | 7932676 | 1 | 1 | |
| 2024-06-17 | 8-K | 8-K | 5.02 | 0001193125-24-162652 | 001-37587 | 241048798 | 34 | 150197 | 1 | 1 |
| 2024-06-14 | 4 | xslF345X05/form4.xml | 0001610717-24-000339 | 7403 | ||||||
| 2024-05-22 | SC 13G | JHBIFCytomX051324.txt | 0001274173-24-000069 | 005-89140 | 24973269 | 34 | 12959 | |||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000248 | 5328 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000247 | 5259 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000246 | 5313 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000245 | 5300 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000244 | 5314 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000243 | 5325 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4.xml | 0001610717-24-000242 | 5326 | ||||||
| 2024-05-17 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-24-141699 | 001-37587 | 24959447 | 34 | 201843 | 1 | 1 |
| 2024-05-13 | SC 13G | sc13g.htm | 0000929638-24-001775 | 005-89140 | 24938838 | 34 | 113377 | |||
| 2024-05-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-134284 | 001-37587 | 24926938 | 34 | 177424 | 1 | 1 |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-055598 | 001-37587 | 24925785 | 34 | 387329 | 1 | 1 |
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055588 | 001-37587 | 24925724 | 34 | 6932748 | 1 | 1 | |
| 2024-05-01 | DEFA14A | DEFA14A | 0001193125-24-126170 | 001-37587 | 24899836 | 34 | 20383 | |||
| 2024-04-04 | DEFA14A | DEFA14A | 0001140361-24-017973 | 001-37587 | 24823563 | 34 | 3926391 | |||
| 2024-04-04 | DEF 14A | DEF 14A | 0001140361-24-017969 | 001-37587 | 24823540 | 34 | 2810224 | |||
| 2024-03-28 | 4 | xslF345X05/form4.xml | 0001610717-24-000190 | 7671 | ||||||
| 2024-03-25 | PRE 14A | PRE 14A | 0001140361-24-015062 | 001-37587 | 24780152 | 34 | 2836498 | |||
| 2024-03-22 | 4 | xslF345X05/form4.xml | 0001610717-24-000181 | 5308 | ||||||
| 2024-03-22 | 3 | xslF345X02/form3.xml | 0001610717-24-000180 | 10447 | ||||||
| 2024-03-22 | 8-K | 8-K | 5.02,5.03,9.01 | 0001193125-24-075211 | 001-37587 | 24775242 | 34 | 324395 | 1 | 1 |
| 2024-03-21 | 4 | xslF345X05/form4.xml | 0001610717-24-000179 | 4648 | ||||||
| 2024-03-21 | 4 | xslF345X05/form4.xml | 0001610717-24-000178 | 5569 | ||||||
| 2024-03-21 | 4 | xslF345X05/form4.xml | 0001610717-24-000177 | 4733 | ||||||
| 2024-03-21 | 4 | xslF345X05/form4.xml | 0001610717-24-000176 | 4724 | ||||||
| 2024-03-21 | 4 | xslF345X05/form4.xml | 0001610717-24-000175 | 6117 | ||||||
| 2024-03-11 | S-8 | S-8 | 0001193125-24-064845 | 333-277819 | 24738475 | 33 | 78561 | |||
| 2024-03-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-029207 | 001-37587 | 24737925 | 34 | 367225 | 1 | 1 |
| 2024-03-11 | 10-K | 10-K | 0000950170-24-029191 | 001-37587 | 24737906 | 34 | 13046457 | 1 | 1 | |
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-002867 | 005-89140 | 24637365 | 34 | 85445 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-000454 | 005-89140 | 24633512 | 34 | 283569 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020727 | 005-89140 | 24627896 | 34 | 13108 | |||
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000036 | 10612 | ||||||
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000035 | 9689 | ||||||
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000034 | 9774 | ||||||
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000033 | 11158 | ||||||
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000032 | 9764 | ||||||
| 2024-01-19 | 4 | xslF345X05/form4.xml | 0001610717-24-000031 | 9734 | ||||||
| 2023-12-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000423 | 5593 | ||||||
| 2023-12-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000422 | 4747 | ||||||
| 2023-12-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000421 | 6140 | ||||||
| 2023-12-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000420 | 4671 | ||||||
| 2023-12-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000419 | 4757 | ||||||
| 2023-12-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000412 | 7350 | ||||||
| 2023-12-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000411 | 8008 | ||||||
| 2023-12-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000410 | 8790 | ||||||
| 2023-12-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000409 | 7322 | ||||||
| 2023-12-19 | 4 | xslF345X05/form4.xml | 0001610717-23-000408 | 7163 | ||||||
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-060221 | 001-37587 | 231383619 | 34 | 502291 | 1 | 1 |
| 2023-11-07 | 10-Q | 10-Q | 0000950170-23-060201 | 001-37587 | 231383533 | 34 | 10253515 | 1 | 1 | |
| 2023-09-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000299 | 6373 | ||||||
| 2023-09-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000298 | 7765 | ||||||
| 2023-09-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000297 | 7219 | ||||||
| 2023-09-22 | 4 | xslF345X05/form4.xml | 0001610717-23-000296 | 6296 | ||||||
| 2023-08-28 | 424B3 | 424B3 | 0001193125-23-221648 | 333-274010 | 231209465 | 33 | 188250 | |||
| 2023-08-25 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-08-25 16:00:00 | 9999999995-23-002501 | 333-274010 | 231209950 | 33 | 1744 | ||
| 2023-08-24 | 8-K | 8-K | 1.01 | 0001193125-23-220087 | 001-37587 | 231202197 | 34 | 145587 | 1 | 1 |
| 2023-08-23 | CORRESP | filename1.htm | 0001193125-23-219080 | 10118 | ||||||
| 2023-08-22 | UPLOAD | filename1.pdf | 0000000000-23-009183 | 40297 | ||||||
| 2023-08-17 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-23-006953 | 021-489946 | 231179313 | 33 | 13971 | ||
| 2023-08-16 | S-3 | S-3 | 0001193125-23-213683 | 333-274010 | 231176371 | 33 | 307827 | |||
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039793 | 001-37587 | 231151300 | 34 | 441863 | 1 | 1 |
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039761 | 001-37587 | 231151104 | 34 | 9889087 | 1 | 1 | |
| 2023-07-20 | 4 | xslF345X05/form4.xml | 0001610717-23-000208 | 5396 | ||||||
| 2023-07-20 | 3 | FORM 3 | 0001567619-23-006641 | 10756 | ||||||
| 2023-07-03 | 8-K | 8-K | 1.01,3.02,9.01 | 0001193125-23-180722 | 001-37587 | 231063154 | 34 | 734038 | 1 | 1 |
| 2023-06-20 | 8-K | 8-K | 5.07 | 0001193125-23-170124 | 001-37587 | 231025059 | 34 | 155056 | 1 | 1 |
| 2023-06-16 | 4 | xslF345X04/form4.xml | 0001610717-23-000183 | 5188 | ||||||
| 2023-06-16 | 4 | xslF345X04/form4.xml | 0001610717-23-000182 | 5201 | ||||||
| 2023-06-16 | 4 | xslF345X04/form4.xml | 0001610717-23-000181 | 5216 | ||||||
| 2023-06-16 | 4 | xslF345X04/form4.xml | 0001610717-23-000180 | 5214 | ||||||
| 2023-06-16 | 4 | xslF345X04/form4.xml | 0001610717-23-000179 | 5213 | ||||||
| 2023-06-16 | 4 | xslF345X04/form4.xml | 0001610717-23-000178 | 5202 | ||||||
| 2023-05-23 | 4 | xslF345X04/form4.xml | 0001610717-23-000061 | 7375 | ||||||
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-019674 | 001-37587 | 23902117 | 34 | 457194 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019654 | 001-37587 | 23902052 | 34 | 8504143 | 1 | 1 | |
| 2023-04-27 | DEFA14A | DEFA14A | 0001140361-23-020949 | 001-37587 | 23857215 | 34 | 3968177 | |||
| 2023-04-27 | DEF 14A | DEF 14A | 0001140361-23-020944 | 001-37587 | 23857168 | 34 | 3165919 | |||
| 2023-03-31 | 4 | xslF345X04/form4.xml | 0001140361-23-015503 | 4151 | ||||||
| 2023-03-29 | 4 | xslF345X04/form4.xml | 0001140361-23-014592 | 4806 | ||||||
| 2023-03-29 | 3 | xslF345X02/form3.xml | 0001140361-23-014591 | 29052 | ||||||
| 2023-03-27 | S-8 | S-8 | 0001193125-23-080477 | 333-270869 | 23764773 | 33 | 86512 | |||
| 2023-03-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-009999 | 001-37587 | 23764672 | 34 | 463277 | 1 | 1 |
| 2023-03-27 | 10-K | 10-K | 0000950170-23-009991 | 001-37587 | 23764648 | 34 | 24013025 | 1 | 1 | |
| 2023-03-27 | 10-K/A | 10-K/A | 0000950170-23-009984 | 001-37587 | 23764574 | 34 | 33415617 | 1 | 1 | |
| 2023-03-20 | 4 | xslF345X04/form4.xml | 0001140361-23-012619 | 4618 | ||||||
| 2023-03-20 | 4 | xslF345X04/form4.xml | 0001140361-23-012618 | 5455 | ||||||
| 2023-03-20 | 4 | xslF345X04/form4.xml | 0001140361-23-012617 | 4546 | ||||||
| 2023-03-20 | 4 | xslF345X04/form4.xml | 0001140361-23-012616 | 4533 | ||||||
| 2023-03-20 | 4 | xslF345X04/form4.xml | 0001140361-23-012615 | 6003 | ||||||
| 2023-03-20 | 4 | xslF345X04/form4.xml | 0001140361-23-012614 | 4616 | ||||||
| 2023-03-10 | 8-K | 8-K | 7.01 | 0001193125-23-067531 | 001-37587 | 23723393 | 34 | 148358 | 1 | 1 |
| 2023-02-24 | 8-K | 8-K | 4.02 | 0001193125-23-047460 | 001-37587 | 23662311 | 34 | 153418 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SCHEDULE 13G/A, AMENDMENT #2 | 0000899140-23-000386 | 005-89140 | 23629421 | 34 | 52284 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-23-002395 | 005-89140 | 23628405 | 34 | 85556 | |||
| 2023-02-14 | SC 13G/A | CYTOMX THERAPEUTICS, INC. | 0000902664-23-001738 | 005-89140 | 23624014 | 34 | 61099 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015751 | 005-89140 | 23602915 | 34 | 12996 | |||
| 2023-02-06 | 4 | FORM 4 | 0001567619-23-001930 | 10829 | ||||||
| 2023-02-06 | 4 | FORM 4 | 0001567619-23-001929 | 11414 | ||||||
| 2023-02-06 | 4 | FORM 4 | 0001567619-23-001928 | 10126 | ||||||
| 2023-02-06 | 4 | FORM 4 | 0001567619-23-001927 | 10215 | ||||||
| 2023-01-05 | 8-K | 8-K | 1.01 | 0001193125-23-002398 | 001-37587 | 23511432 | 34 | 154622 | 1 | 1 |
| 2022-11-22 | 8-K | 8-K | 1.01 | 0001193125-22-290176 | 001-37587 | 221407191 | 34 | 153425 | 1 | 1 |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023210 | 001-37587 | 221368945 | 34 | 532495 | 1 | 1 |
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023190 | 001-37587 | 221368795 | 34 | 9393008 | 1 | 1 | |
| 2022-09-26 | CT ORDER | filename1.pdf | 20220926,20220926 | 9999999997-22-004269 | 001-37587 | 221264997 | 34 | 129924 | ||
| 2022-09-23 | 8-K | 8-K | 5.02 | 0001193125-22-250137 | 001-37587 | 221262398 | 34 | 147370 | 1 | 1 |
| 2022-09-13 | 8-K | 8-K | 5.02 | 0001193125-22-243709 | 001-37587 | 221240863 | 34 | 148404 | 1 | 1 |
| 2022-08-12 | 4 | FORM 4 | 0001567619-22-015868 | 8026 | ||||||
| 2022-08-12 | 4 | FORM 4 | 0001567619-22-015866 | 8076 | ||||||
| 2022-08-12 | 4 | FORM 4 | 0001567619-22-015864 | 8081 | ||||||
| 2022-08-12 | 4 | FORM 4 | 0001567619-22-015863 | 7999 | ||||||
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-014751 | 001-37587 | 221136681 | 34 | 512235 | 1 | 1 |
| 2022-08-04 | 10-Q | 10-Q | 0000950170-22-014737 | 001-37587 | 221136533 | 34 | 7851453 | 1 | 1 | |
| 2022-07-29 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-22-002304 | 005-89140 | 221121354 | 34 | 277763 | |||
| 2022-07-25 | SC 13G | p722221sc13g.htm | 0001214659-22-009141 | 005-89140 | 221103308 | 34 | 92555 | |||
| 2022-07-21 | 4 | FORM 4 | 0001567619-22-014301 | 6944 | ||||||
| 2022-07-21 | 4 | FORM 4 | 0001567619-22-014300 | 8327 | ||||||
| 2022-07-21 | 4 | FORM 4 | 0001567619-22-014299 | 7525 | ||||||
| 2022-07-21 | 4 | FORM 4 | 0001567619-22-014298 | 6634 | ||||||
| 2022-07-21 | 4 | FORM 4 | 0001567619-22-014297 | 6667 | ||||||
| 2022-07-21 | 4 | FORM 4 | 0001567619-22-014296 | 6643 | ||||||
| 2022-07-13 | 8-K | 8-K | 2.05,5.02 | 0001193125-22-192874 | 001-37587 | 221081173 | 34 | 150545 | 1 | 1 |
| 2022-07-08 | SC 13G | us23284f1057_070822.txt | 0000834237-22-010281 | 005-89140 | 221075042 | 34 | 12220 | |||
| 2022-07-06 | 8-K | 8-K | 8.01 | 0001193125-22-188577 | 001-37587 | 221068791 | 34 | 149190 | 1 | 1 |
| 2022-06-21 | 8-K | 8-K | 5.07 | 0001193125-22-177650 | 001-37587 | 221028310 | 34 | 154901 | 1 | 1 |
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013075 | 5557 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013074 | 5542 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013073 | 5529 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013072 | 5554 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013071 | 5490 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013070 | 5543 | ||||||
| 2022-06-17 | 4 | FORM 4 | 0001567619-22-013069 | 5555 | ||||||
| 2022-05-11 | 4 | FORM 4 | 0001567619-22-010091 | 11210 | ||||||
| 2022-05-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-007835 | 001-37587 | 22896389 | 34 | 426819 | 1 | 1 |
| 2022-05-05 | 10-Q | 10-Q | 0000950170-22-007806 | 001-37587 | 22896154 | 34 | 6897830 | 1 | 1 | |
| 2022-04-27 | DEFA14A | DEFA14A | 0001140361-22-016245 | 001-37587 | 22859938 | 34 | 5277506 | |||
| 2022-04-27 | DEF 14A | DEF 14A | 0001140361-22-016242 | 001-37587 | 22859904 | 34 | 3066869 | |||
| 2022-04-14 | 8-K | 8-K | 5.02 | 0001193125-22-105580 | 001-37587 | 22827445 | 34 | 142678 | 1 | 1 |
| 2022-03-28 | 3 | FORM 3 | 0001567619-22-007578 | 20041 | ||||||
| 2022-03-23 | 8-K | 8-K | 5.02 | 0001193125-22-082793 | 001-37587 | 22763590 | 34 | 142358 | 1 | 1 |
| 2022-03-09 | 3 | FORM 3 | 0001567619-22-006664 | 15767 | ||||||
| 2022-03-04 | 424B5 | FORM 424B5 | 0001193125-22-066325 | 333-258510 | 22715323 | 33 | 580423 | |||
| 2022-03-04 | S-8 | S-8 | 0001193125-22-066309 | 333-263321 | 22715201 | 33 | 77448 | |||
| 2022-03-01 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-002526 | 001-37587 | 22698073 | 34 | 438890 | 1 | 1 |
| 2022-03-01 | 10-K | 10-K | 0000950170-22-002519 | 001-37587 | 22697950 | 34 | 16107361 | 1 | 1 | |
| 2022-02-14 | SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 2) | 0000899140-22-000335 | 005-89140 | 22633549 | 34 | 54160 | |||
| 2022-02-14 | 8-K | 8-K | 5.02 | 0001193125-22-041752 | 001-37587 | 22632213 | 34 | 144885 | 1 | 1 |
| 2022-02-14 | SC 13G/A | CYTOMX THERAPEUTICS, INC. | 0001104659-22-022771 | 005-89140 | 22631933 | 34 | 93978 | |||
| 2022-02-14 | SC 13G/A | CYTOMX THERAPEUTICS, INC. | 0000902664-22-001608 | 005-89140 | 22625837 | 34 | 63134 | |||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016943 | 005-89140 | 22606950 | 34 | 12997 | |||
| 2022-02-07 | 8-K | 8-K | 5.02 | 0001193125-22-029142 | 001-37587 | 22595644 | 34 | 144290 | 1 | 1 |
| 2022-02-04 | 4 | FORM 4 | 0001567619-22-002525 | 7625 | ||||||
| 2022-02-04 | 4 | FORM 4 | 0001567619-22-002524 | 7542 | ||||||
| 2022-02-04 | 4 | FORM 4 | 0001567619-22-002523 | 7578 | ||||||
| 2022-02-04 | 4 | FORM 4 | 0001567619-22-002522 | 7554 | ||||||
| 2022-02-04 | 4 | FORM 4 | 0001567619-22-002521 | 8434 | ||||||
| 2022-02-03 | SC 13G/A | us23284f1057_020322.txt | 0000834237-22-006265 | 005-89140 | 22588998 | 34 | 13181 | |||
| 2022-02-01 | SC 13G/A | cytomx13ga2_123121.htm | 0001040188-22-000014 | 005-89140 | 22577767 | 34 | 40583 | |||
| 2022-01-10 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-22-000174 | 001-37587 | 22519745 | 34 | 2673779 | 1 | 1 |
| 2022-01-03 | SC 13G | sc13g07422010_01032022.htm | 0000921895-22-000008 | 005-89140 | 22502593 | 34 | 284302 | |||
| 2021-12-29 | CT ORDER | filename1.pdf | 20211229,20211229 | 9999999997-21-006041 | 001-37587 | 211526929 | 34 | 128927 | ||
| 2021-12-08 | SC 13G | formsc13g.htm | 0001493152-21-030804 | 005-89140 | 211478366 | 34 | 159425 | |||
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-003067 | 001-37587 | 211380107 | 34 | 469857 | 1 | 1 |
| 2021-11-04 | 10-Q | 10-Q | 0000950170-21-003053 | 001-37587 | 211379937 | 34 | 9023149 | 1 | 1 | |
| 2021-10-26 | 4 | FORM 4 | 0001567619-21-018720 | 8075 | ||||||
| 2021-10-26 | 4 | FORM 4 | 0001567619-21-018719 | 8031 | ||||||
| 2021-10-26 | 4 | FORM 4 | 0001567619-21-018718 | 8114 | ||||||
| 2021-10-26 | 4 | FORM 4 | 0001567619-21-018717 | 8043 | ||||||
| 2021-10-26 | 4 | FORM 4 | 0001567619-21-018716 | 8067 | ||||||
| 2021-10-07 | 4 | FORM 4 | 0001567619-21-018045 | 5616 | ||||||
| 2021-10-07 | 3 | FORM 3 | 0001567619-21-018044 | 10885 | ||||||
| 2021-10-04 | 8-K | 8-K | 5.02 | 0001193125-21-290428 | 001-37587 | 211301143 | 34 | 150373 | 1 | 1 |
| 2021-08-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-08-18 16:00:00 | 9999999995-21-003235 | 333-258510 | 211188311 | 33 | 1713 | ||
| 2021-08-17 | S-3/A | S-3/A | 0001193125-21-248190 | 333-258510 | 211180776 | 33 | 331929 | |||
| 2021-08-16 | CORRESP | filename1.htm | 0001193125-21-248193 | 7622 | ||||||
| 2021-08-13 | 4 | FORM 4 | 0001567619-21-015554 | 7958 | ||||||
| 2021-08-12 | UPLOAD | filename1.pdf | 0000000000-21-009876 | 40277 | ||||||
| 2021-08-05 | S-3 | S-3 | 0001193125-21-237879 | 333-258510 | 211149337 | 33 | 658295 | |||
| 2021-08-05 | 10-Q | 10-Q | 0000950170-21-000946 | 001-37587 | 211148700 | 34 | 8370506 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-000939 | 001-37587 | 211148486 | 34 | 443363 | 1 | 1 |
| 2021-06-22 | 8-K | 8-K | 5.07 | 0001193125-21-195380 | 001-37587 | 211032548 | 34 | 159490 | 1 | 1 |
| 2021-06-21 | 4 | FORM 4 | 0001567619-21-012419 | 6080 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012372 | 5542 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012371 | 5557 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012369 | 5520 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012368 | 5529 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012367 | 5543 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012365 | 5490 | ||||||
| 2021-06-17 | 4 | FORM 4 | 0001567619-21-012364 | 5554 | ||||||
| 2021-06-16 | 4 | FORM 4 | 0001567619-21-012252 | 11039 | ||||||
| 2021-06-08 | 4 | FORM 4 | 0001567619-21-011808 | 5915 | ||||||
| 2021-06-08 | 4 | FORM 4 | 0001567619-21-011807 | 4731 | ||||||
| 2021-06-08 | 4 | FORM 4 | 0001567619-21-011806 | 4802 | ||||||
| 2021-05-06 | S-8 | S-8 | 0001193125-21-153339 | 333-255832 | 21898266 | 33 | 73186 | |||
| 2021-05-06 | 10-Q | 10-Q - Q1/2021 | 0001564590-21-024969 | 001-37587 | 21897889 | 34 | 8255869 | 1 | 1 | |
| 2021-05-06 | 8-K | 8-K-050621 Q1-21 EARNINGS | 2.02,9.01 | 0001564590-21-024964 | 001-37587 | 21897834 | 34 | 488470 | 1 | 1 |
| 2021-05-03 | SC 13G/A | AMENDMENT NO. 3 TO THE SCHEDULE 13G | 0000921895-21-001197 | 005-89140 | 21884720 | 34 | 279063 | |||
| 2021-04-28 | DEFA14A | DEFA14A | 0001140361-21-014778 | 001-37587 | 21864810 | 34 | 1649314 | |||
| 2021-04-28 | DEF 14A | DEF 14A | 0001140361-21-014772 | 001-37587 | 21864729 | 34 | 2725505 | |||
| 2021-04-02 | 4 | FORM 4 | 0001567619-21-007541 | 8841 | ||||||
| 2021-03-05 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000557 | 275638 | ||||||
| 2021-03-04 | 8-K | 8-K | 5.02 | 0001193125-21-069514 | 001-37587 | 21714358 | 34 | 155438 | 1 | 1 |
| 2021-03-02 | 4 | FORM 4 | 0001567619-21-005402 | 5648 | ||||||
| 2021-03-02 | 4 | FORM 4 | 0001567619-21-005399 | 5577 | ||||||
| 2021-03-02 | 4 | FORM 4 | 0001567619-21-005398 | 5601 | ||||||
| 2021-03-02 | 4 | FORM 4 | 0001567619-21-005397 | 5565 | ||||||
| 2021-03-02 | 4 | FORM 4 | 0001567619-21-005396 | 7676 | ||||||
| 2021-02-24 | S-8 | S-8 | 0001193125-21-054696 | 333-253452 | 21673682 | 33 | 84321 | |||
| 2021-02-24 | 8-K | 8-K - YE 2020 EARNINGS | 2.02,9.01 | 0001564590-21-008088 | 001-37587 | 21673194 | 34 | 472430 | 1 | 1 |
| 2021-02-24 | 10-K | 10-K | 0001564590-21-008081 | 001-37587 | 21673103 | 34 | 18575845 | 1 | 1 | |
| 2021-02-18 | 4 | OWNERSHIP DOCUMENT | 0000921895-21-000498 | 24303 | ||||||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001193125-21-044791 | 005-89140 | 21637596 | 34 | 66561 | |||
| 2021-02-11 | SC 13G/A | AMENDMENT NO. 2 TO THE SCHEDULE 13G | 0000921895-21-000340 | 005-89140 | 21621113 | 34 | 279075 | |||
| 2021-02-10 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017882 | 005-89140 | 21610535 | 34 | 13861 | |||
| 2021-02-04 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000459 | 276977 | ||||||
| 2021-02-02 | SC 13G/A | cytomx13ga1_123120.htm | 0001040188-21-000039 | 005-89140 | 21580875 | 34 | 40615 | |||
| 2021-01-29 | SC 13G | SCHEDULE 13G | 0001104659-21-009413 | 005-89140 | 21571600 | 34 | 90386 | |||
| 2021-01-29 | SC 13G/A | us23284f1057_012921.txt | 0000834237-21-003749 | 005-89140 | 21568707 | 34 | 13330 | |||
| 2021-01-26 | SC 13G | SCHEDULE 13G | 0000899140-21-000089 | 005-89140 | 21555326 | 34 | 60914 | |||
| 2021-01-25 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-016452 | 001-37587 | 21550767 | 34 | 417211 | 1 | 1 |
| 2021-01-21 | 424B5 | 424B5 | 0001193125-21-013638 | 333-228203 | 21542762 | 33 | 763622 | |||
| 2021-01-19 | 424B5 | 424B5 | 0001193125-21-011599 | 333-228203 | 21536323 | 33 | 764041 | |||
| 2021-01-19 | 8-K | 8-K | 2.02,8.01 | 0001193125-21-011589 | 001-37587 | 21536301 | 34 | 150645 | 1 | 1 |
| 2020-12-28 | 4 | FORM 4 | 0001567619-20-021619 | 6721 | ||||||
| 2020-12-28 | 3 | OWNERSHIP DOCUMENT | 0000921895-20-003280 | 23606 | ||||||
| 2020-12-22 | 8-K | 8-K | 5.02 | 0001193125-20-324542 | 001-37587 | 201408149 | 34 | 149897 | 1 | 1 |
| 2020-12-18 | 4 | FORM 4 | 0001567619-20-021372 | 5608 | ||||||
| 2020-12-18 | 3 | FORM 3 | 0001567619-20-021370 | 10580 | ||||||
| 2020-12-07 | 4 | FORM 4 | 0001567619-20-020709 | 4802 | ||||||
| 2020-12-07 | 4 | FORM 4 | 0001567619-20-020707 | 4759 | ||||||
| 2020-12-07 | 4 | FORM 4 | 0001567619-20-020706 | 4731 | ||||||
| 2020-11-10 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-20-002869 | 005-89140 | 201301917 | 34 | 279277 | |||
| 2020-11-05 | 8-K | 8-K - Q3-20 EARNINGS | 2.02,9.01 | 0001564590-20-051317 | 001-37587 | 201290582 | 34 | 607781 | 1 | 1 |
| 2020-11-05 | 10-Q | 10-Q Q3/2020 | 0001564590-20-051302 | 001-37587 | 201290464 | 34 | 11243167 | 1 | 1 | |
| 2020-10-06 | 8-K | 8-K | 5.02 | 0001193125-20-264740 | 001-37587 | 201226935 | 34 | 149262 | 1 | 1 |
| 2020-09-23 | 4 | FORM 4 | 0001567619-20-017051 | 6987 | ||||||
| 2020-08-06 | 8-K | 8-K Q2-20 EARNINGS | 2.02,9.01 | 0001564590-20-037749 | 001-37587 | 201081782 | 34 | 372357 | 1 | 1 |
| 2020-08-06 | 10-Q | 10-Q - Q2/2020 | 0001564590-20-037722 | 001-37587 | 201081597 | 34 | 9186713 | 1 | 1 | |
| 2020-06-23 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-20-176532 | 001-37587 | 20982067 | 34 | 188688 | 1 | 1 |
| 2020-06-19 | 4 | FORM 4 | 0001567619-20-012433 | 5529 | ||||||
| 2020-06-18 | 4 | FORM 4 | 0001567619-20-012361 | 5519 | ||||||
| 2020-06-17 | 4 | FORM 4 | 0001567619-20-012304 | 13811 | ||||||
| 2020-06-17 | 4 | FORM 4 | 0001567619-20-012301 | 5547 | ||||||
| 2020-06-17 | 4 | FORM 4 | 0001567619-20-012300 | 13763 | ||||||
| 2020-06-17 | 4 | FORM 4 | 0001567619-20-012299 | 5553 | ||||||
| 2020-06-17 | 4 | FORM 4 | 0001567619-20-012298 | 13980 | ||||||
| 2020-06-02 | 4 | FORM 4 | 0001567619-20-011542 | 4761 | ||||||
| 2020-05-29 | 8-K | 8-K | 8.01 | 0001193125-20-155943 | 001-37587 | 20929165 | 34 | 501512 | 1 | 1 |
| 2020-05-14 | 4 | FORM 4 | 0001567619-20-010115 | 8295 | ||||||
| 2020-05-07 | 8-K | 8-K-EARNINGS Q1-20 | 2.02,9.01 | 0001564590-20-022870 | 001-37587 | 20856594 | 34 | 468457 | 1 | 1 |
One latest value per concept from companyfacts (340 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 218.00M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 372.30M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 2.95M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001140361-26-018237 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.89M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001140361-26-018237 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 10.64M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001140361-26-018237 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 4.74M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001140361-26-018237 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 266.25 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-30 | 0001140361-26-018237 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 3,237.75 | 2026-08-04 | S-8 | 2026-08-06 | 0001193125-26-338121 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 3,237.75 | 2026-08-04 | S-8 | 2026-08-06 | 0001193125-26-338121 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 23.45M | 2026-08-04 | S-8 | 2026-08-06 | 0001193125-26-338121 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-04 | S-8 | 2026-08-06 | 0001193125-26-338121 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 501,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 154,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 3.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 16.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 2.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 16.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -315,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.06B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.84M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 3.80M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 5.86M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 13.17M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-03-27 | 0000950170-23-009984 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 80,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 109,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 25.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | Assets | Assets | USD | 364.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 356.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AssetsFairValueDisclosureRecurring | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | USD | 321.19M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 102,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-211868 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-068511 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 336.45M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 279.39M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 110,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 66,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 279.28M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 204.81M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-06 | 0001564590-21-024969 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 336.27M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 314.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | AvailableForSaleSecuritiesNoncurrent | Available-for-sale Securities, Noncurrent | USD | 2.02M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001564590-16-027405 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 1.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 4.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 33.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 72.90M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 79.90M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-12 | 0000950170-25-068511 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 189.34M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 35.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 21.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 82.20M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 3.084 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 81,620 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 15.77M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 170.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 170.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -59.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 53.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice | Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price | USD | 49.17M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-07 | 0001564590-19-041726 |
| us-gaap | ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress | Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress | USD | 10.00M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 27.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 25.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 13.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 1.51M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 27.14M | 2015-10-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 | |
| us-gaap | CumulativeEffectOnRetainedEarningsNetOfTax1 | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | USD | -10.91M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 238,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 238,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | USD | 283,000 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001564590-16-027405 |
| us-gaap | DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax | USD | -315,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | -513,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 932,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | DeferredRentCredit | Deferred Rent Credit | USD | 200,000 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 301.83M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-08 | 0001564590-18-020448 | |
| us-gaap | DeferredRevenueAdditions | Deferred Revenue, Additions | USD | 31.90M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-08 | 0001564590-18-020448 |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 51.51M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-08 | 0001564590-18-020448 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 250.32M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-08 | 0001564590-18-020448 | |
| us-gaap | DeferredRevenueRefundPayments1 | Deferred Revenue, Refund Payments | USD | 14.13M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012382 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 8.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 28.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 188.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 28.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 932,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 84.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 25,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 24.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 9.08M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 2.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent | USD | 1.51M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 187.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 595,000 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssets | Deferred Tax Liabilities, Goodwill and Intangible Assets | USD | 108,000 | 2018-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 947,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 513,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 15,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 164,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | -179,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 500,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | Depreciation | Depreciation | USD | 1.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.25M | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-07 | 0001564590-19-030054 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.16 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.101 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 1.86M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.108 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.027 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 7.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 7.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 1.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 293,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -17,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | -402,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 27.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | Goodwill | Goodwill | USD | 949,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -58.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicAndDilutedShare | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | USD/shares | -0.37 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007806 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -0.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -0.29 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncomeTaxCreditsAndAdjustments | Income Tax Credits and Adjustments | USD | 2.80M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060201 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 13.06M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-03-27 | 0000950170-23-009984 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 13.06M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-051302 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 180,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 1.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -3.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 49,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 142,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 11,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 238,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 39,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -355,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -294,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -1.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncreaseDecreaseInAccountsReceivableRelatedParties | Increase (Decrease) in Accounts Receivable, Related Parties | USD | -154,000 | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -371,000 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-06 | 0001564590-16-018134 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 24.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -26.81M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 56,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-029191 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 6.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IncreaseInRestrictedCash | Increase in Restricted Cash | USD | 817,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 328,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 1.75M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-06 | 0001564590-16-018134 | |
| us-gaap | InterestExpense | Interest Expense | USD | 1.73M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 1.40M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 220,000 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001564590-16-027405 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 7.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-03-27 | 0000950170-23-009984 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 1.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 10.12M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 5.73M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 4.39M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009991 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 4.39M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-11 | 0000950170-24-029191 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 4.39M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.31M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0000950170-21-003053 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 731,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 | |
| us-gaap | Liabilities | Liabilities | USD | 79.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 364.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 1.86M | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001564590-16-027405 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 45.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 14.18M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012382 |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 1.42M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 1.57M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 99.97M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0000950170-21-003053 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 14.00M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-27 | 0000950170-23-009991 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 235.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 2.60M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012382 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -186.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -23.38M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012382 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -26.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -14.61M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-09 | 0001564590-18-012382 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -58.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -58.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 80.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -66.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 5.07M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 5.10M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 9.38M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 526,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 3.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 5.57M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 41.35M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 4.85M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 34.14M | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-06 | 0001564590-16-018134 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 5.27M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 5.13M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 4.99M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 21.11M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 1.17M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 4.20M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.083 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 551,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -426,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 1,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -8,000 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001564590-15-010977 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 4.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 305,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 12,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 2.69M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 15.00M | 2026-03-19 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 161.74M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 99.90M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-03-27 | 0000950170-23-009984 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 99.90M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0000950170-21-003053 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 589,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 376.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 6.71M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2015-10-14 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2015-10-14 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 6.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 81.78M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 228.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 74.43M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 930,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-02 | 0001564590-17-003229 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 830,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 5.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 3.36M | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | -3.07M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 154.50M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-06 | 0001564590-18-027387 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 190.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 100.00M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-08 | 0000950170-23-039761 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 52,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 0 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019654 |
| us-gaap | ProductLiabilityContingencyAccrualDiscountRate | Product Liability Contingency, Accrual, Discount Rate | pure | 0.09 | 2017-09-29 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 | |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -58.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 18.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 3.03M | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-11-03 | 0001564590-16-027405 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 53.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 10.70M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 100,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 917,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-05 | 0001564590-17-008943 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 917,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 610,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | RestructuringAndRelatedCostExpectedCost1 | Restructuring and Related Cost, Expected Cost | USD | 2.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.4 | 2025-01-06 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-211868 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 7.15M | 2022-07-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023190 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 25,000 | 2025-04-01 | 2025-06-30 | 2025 | Q3 | 10-Q | 2025-11-06 | 0001193125-25-269477 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 24,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | RestructuringReserveTranslationAndOtherAdjustment | Restructuring Reserve, Translation and Other Adjustment | USD | -77,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -770.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 13.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 2.20M | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | Revenues | Revenues | USD | 13.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-03-27 | 0000950170-23-009984 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 5.3 | 2026-03-19 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 10.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.689 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.629 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.019 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.014 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 2.90M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 12.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 11.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 6.63 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 470,100 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 3,811 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 779,898 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 9.028 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022252 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 425,574 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 4.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.41 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 24.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 20.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.04 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 6.84M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 10.93M | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 10.77 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-24 | 0001564590-21-008081 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 2.80M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.68 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 1.071 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 11.38 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 5.07 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 7.853 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 4.52M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 7.80M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 77.50M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001564590-15-010977 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 284.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.016 | 2015-10-01 | 2015-10-02 | 2016 | FY | 10-K | 2017-03-02 | 0001564590-17-003229 |
| us-gaap | StockholdersEquityNoteSubscriptionsReceivable | Stockholders' Equity Note, Subscriptions Receivable | USD | 78,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-02 | 0001564590-17-003229 | |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 383,346 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034575 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 346,998 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 246,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 159,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-27 | 0001564590-19-004890 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 228.35M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 94,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 1.19M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | TaxCutsAndJobsActOf2017ReclassificationFromAociToRetainedEarningsTaxEffect | Tax Cuts and Jobs Act, Reclassification from AOCI to Retained Earnings, Tax Effect | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K/A | 2023-03-27 | 0000950170-23-009984 |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 13.34M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-27 | 0001564590-20-007395 | |
| us-gaap | TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests | Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests | USD | 159.08M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-23 | 0001564590-15-010977 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 22.00M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 18.70M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-07 | 0001564590-18-004727 | |
| us-gaap | TemporaryEquityValueExcludingAdditionalPaidInCapital | Temporary Equity, Par Value | USD | 76.71M | 2014-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 20.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 400,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-060201 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 4.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense | Unrecognized Tax Benefits, Income Tax Penalties Expense | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 213,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | -41,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-03-07 | 0001564590-16-014091 |
| us-gaap | UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense | Unrecognized Tax Benefits, Interest on Income Taxes Expense | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 2.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 5.00M | 2023-09-01 | 2023-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107146 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 205.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 65.39M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0000950170-22-007806 |
| us-gaap | WeightedAverageNumberOfSharesContingentlyIssuable | Weighted Average Number of Shares, Contingently Issuable | shares | 846,637 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 204.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 205.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449739 |